CNBX Pharmaceuticals Inc. Quarterly Common Stock, Shares, Issued from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
CNBX Pharmaceuticals Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2010 to Q3 2024.
  • CNBX Pharmaceuticals Inc. Common Stock, Shares, Issued for the quarter ending August 31, 2024 was 31.1M shares, a 37.6% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 31.1M +8.5M +37.6% Aug 31, 2024 10-K 2024-11-29
Q2 2024 3.11M -12.9M -80.6% May 31, 2024 10-Q 2024-07-15
Q1 2024 3.11M +902K +40.8% Feb 29, 2024 10-Q 2024-04-16
Q4 2023 28.3M +27.1M +2151% Nov 30, 2023 10-Q 2024-01-12
Q3 2023 22.6M +21.4M +1725% Aug 31, 2023 10-K 2024-11-29
Q2 2023 16M +14.8M +1194% May 31, 2023 10-Q 2023-07-14
Q1 2023 2.21M -147M -98.5% Feb 28, 2023 10-Q 2023-04-14
Q4 2022 1.26M -147M -99.2% Nov 30, 2022 10-Q 2023-01-13
Q3 2022 1.24M -147M -99.2% Aug 31, 2022 10-K 2023-11-30
Q2 2022 1.24M -141M -99.1% May 31, 2022 10-Q 2022-07-14
Q1 2022 149M +14.2M +10.5% Feb 28, 2022 10-Q 2022-04-12
Q4 2021 149M +13.4M +9.93% Nov 30, 2021 10-Q 2022-01-13
Q3 2021 149M +13.6M +10.1% Aug 31, 2021 10-K 2022-11-30
Q2 2021 143M +7.5M +5.55% May 31, 2021 10-Q 2021-07-14
Q1 2021 135M +202K +0.15% Feb 28, 2021 10-Q 2021-04-14
Q4 2020 135M +819K +0.61% Nov 30, 2020 10-Q 2021-01-14
Q3 2020 135M +582K +0.43% Aug 31, 2020 10-K 2021-11-29
Q2 2020 135M +622K +0.46% May 31, 2020 10-Q 2020-07-14
Q1 2020 135M +2.84M +2.15% Feb 29, 2020 10-Q 2020-04-13
Q4 2019 134M +2.59M +1.96% Nov 30, 2019 10-Q 2020-01-14
Q3 2019 134M +12.9M +10.6% Aug 31, 2019 10-K 2020-11-04
Q2 2019 134M +13.6M +11.3% May 31, 2019 10-Q 2019-07-15
Q1 2019 132M +11.7M +9.72% Feb 28, 2019 10-Q 2019-04-15
Q4 2018 132M +12.3M +10.3% Nov 30, 2018 10-Q 2019-01-17
Q3 2018 122M +2.03M +1.7% Aug 31, 2018 10-K 2019-11-29
Q2 2018 121M +2.5M +2.11% May 31, 2018 10-Q 2018-07-16
Q1 2018 120M +5.81M +5.07% Feb 28, 2018 10-Q 2018-04-05
Q4 2017 120M +5.49M +4.81% Nov 30, 2017 10-Q 2018-01-16
Q3 2017 120M +12.3M +11.5% Aug 31, 2017 10-K 2018-11-29
Q2 2017 118M +11.3M +10.6% May 31, 2017 10-Q 2017-07-17
Q1 2017 115M +12M +11.7% Feb 28, 2017 10-Q 2017-04-14
Q4 2016 114M +11.9M +11.7% Nov 30, 2016 10-Q 2017-01-17
Q3 2016 107M +5.72M +5.63% Aug 31, 2016 10-K 2017-12-08
Q2 2016 107M +6.3M +6.26% May 31, 2016 10-Q 2016-07-13
Q1 2016 103M +2.02M +2.01% Feb 29, 2016 10-Q 2016-04-18
Q4 2015 102M +1.52M +1.51% Nov 30, 2015 10-Q/A 2016-04-08
Q3 2015 102M +1.25M +1.25% Aug 31, 2015 10-K 2016-12-13
Q2 2015 101M +19M +23.2% May 31, 2015 10-Q/A 2015-11-17
Q1 2015 101M +79.8M +382% Feb 28, 2015 10-Q/A 2015-11-17
Q4 2014 101M +80M +387% Nov 30, 2014 10-Q/A 2015-11-17
Q3 2014 100M +98.9M +7269% Aug 31, 2014 10-K 2016-01-07
Q2 2014 81.8M +81.1M +11920% May 31, 2014 10-Q/A 2014-07-15
Q1 2014 20.9M +20.2M +2970% Feb 28, 2014 10-Q 2014-04-01
Q4 2013 20.7M +20M +2940% Nov 30, 2013 10-Q 2014-01-14
Q3 2013 1.36M +680K +100% Aug 31, 2013 10-K/A 2015-10-23
Q2 2013 680K May 31, 2013 10-Q 2013-07-15
Q1 2013 680K 0 0% Feb 28, 2013 10-Q 2013-04-15
Q4 2012 680K 0 0% Nov 30, 2012 10-Q 2013-01-14
Q3 2012 680K 0 0% Aug 31, 2012 10-K 2013-11-29
Q1 2012 680K Feb 29, 2012 10-Q 2012-04-13
Q4 2011 680K Nov 30, 2011 10-Q 2012-01-13
Q3 2011 680K 0 0% Aug 31, 2011 10-K 2012-11-30
Q2 2011 680K May 31, 2011 10-Q 2012-07-06
Q3 2010 680K Aug 31, 2010 10-Q 2012-07-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.